NovMetaPharma Co., Ltd. engages in the manufacture and sale of biological drugs for insulin resistance and related metabolic diseases. Its business areas include new medicine development and healthy foods. Its products include medicines for diabetes, obesity, Alzheimer's disease, immunity cure, osteoporosis, and non-alcoholic fatty liver. The company was founded on November 4, 2010 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company